Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.2%

8 terminated/withdrawn out of 658 trials

Success Rate

92.5%

+5.9% vs industry average

Late-Stage Pipeline

12%

77 trials in Phase 3/4

Results Transparency

2 of 99 completed trials have results

Key Signals

187 recruiting2 with results

Enrollment Performance

Analytics

Phase 2

158(38.7%)

N/A

137(33.6%)

Phase 3

53(13.0%)

Phase 1

31(7.6%)

Phase 4

24(5.9%)

Early Phase 1

5(1.2%)

408Total

Phase 2(158)

N/A(137)

Phase 3(53)

Phase 1(31)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (658)

Showing 20 of 658 trials

NCT07854626Not ApplicableNot Yet Recruiting

Venipuncture Via Nurse-AI Collaboration

Role: lead

NCT07856069Phase 2Not Yet Recruiting

Arsenic Trioxide Combined With Chemotherapy for Relapsed SHH-Activated and/or TP53-Mutant Medulloblastoma

Role: lead

NCT07856355Phase 4Not Yet Recruiting

Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated Pneumonia

Role: collaborator

NCT07853053Phase 1Not Yet Recruiting

DV Plus Toripalimab With Cetirizine and Mecobalamin Pretreatment in Patients With Locally Advanced Unresectable or Metastatic Bladder Cancer

Role: lead

NCT06423170Phase 2Recruiting

A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs

Role: lead

NCT06716073Not ApplicableRecruiting

Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

Role: lead

NCT06652113Not ApplicableRecruiting

Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab

Role: lead

NCT05500261Not ApplicableNot Yet Recruiting

Intranasal Dexmedetomidine for Severe Dental Anxiety: a Randomized Trial

Role: lead

NCT07846345Not ApplicableRecruiting

Case Management for Microtia

Role: collaborator

NCT06627712Phase 3Recruiting

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Role: collaborator

NCT05812040Not ApplicableCompleted

Clinical Value of Breast High-Resolution MR Ductography in Patients With Pathological Nipple Discharge

Role: lead

NCT07830797Phase 3Not Yet Recruiting

Absorbable Hemostatic Fluid Gelatin Trial

Role: collaborator

NCT05165225Phase 2Active Not Recruiting

Phase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial

Role: lead

NCT07822789Active Not Recruiting

Chidamide in HR-AML

Role: collaborator

NCT07796880Phase 2Recruiting

Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive， Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

Role: lead

NCT07806292Phase 2Recruiting

Anlotinib + Benmelstobart + HAIC in Unresectable HCC: A Phase II Study

Role: lead

NCT07807410Not ApplicableRecruiting

Early Endotoxin Burden Reduction With oXiris in Septic Shock Patients Requiring CRRT

Role: lead

NCT07801183Phase 4Not Yet Recruiting

Efficacy and Safety of Anrikefon Injection for Multimodal Postoperative Analgesia in Patients Undergoing Laparoscopic Hepatectomy

Role: lead

NCT07179744Recruiting

Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer